HCPCS Level II · Drugs administered other than oral method
J2400Injection, chloroprocaine hydrochloride, per 30 ml
Terminated 12/31/2022
Source: CMS HCPCS quarterly update, October 2026. Page updated September 29, 2026.
About J2400
J2400 is an HCPCS Level II code in the J series (drugs administered other than oral method), describing injection, chloroprocaine hydrochloride, per 30 ml.
It was added to HCPCS effective 01/01/1986, and its current record took effect 01/01/2023.
It was terminated on 12/31/2022 and can't be billed for later dates of service.
Its Medicare coverage code is "D", meaning special Medicare coverage instructions apply.
Details
- Short description
- Chloroprocaine hcl injection
- Date added
- 01/01/1986
- Action effective
- 01/01/2023
- Termination date
- 12/31/2022
- BETOS
- O1E
Related J24xx codes
- J2401Injection, chloroprocaine hydrochloride, per 1 mg
- J2402Injection, chloroprocaine hydrochloride (clorotekal), per 1 mg
- J2403Chloroprocaine hcl ophthalmic, 3% gel, 1 mg
- J2404Injection, nicardipine, 0.1 mg
- J2405Injection, ondansetron hydrochloride, per 1 mg
- J2406Injection, oritavancin (kimyrsa), 10 mg
- J2407Injection, oritavancin (orbactiv), 10 mg
- J2410Injection, oxymorphone hcl, up to 1 mg
- J2425Injection, palifermin, 50 micrograms
- J2426Injection, paliperidone palmitate extended release (invega sustenna), 1 mg
- J2427Injection, paliperidone palmitate extended release (invega hafyera, or invega trinza), 1 mg
- J2428Injection, paliperidone palmitate extended release (erzofri), 1 mg
Common questions about J2400
Is HCPCS J2400 still valid?
- No. J2400 was terminated on 12/31/2022.
Does Medicare cover J2400?
- Its coverage code is "D": special Medicare coverage instructions apply. Check the local coverage determination for your region.